v3.26.1
Net Loss per Share (Tables)
6 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
For the three months ended June 30, 2026, the dilutive effect of the March 2025 Warrants and the March 2025 Private Placement Warrants issued by the Company is reflected in diluted earnings per share (“EPS”) using the treasury stock method. For the six months ended June 30, 2026 and the three and six months ended June 30, 2025, the net loss, basic and diluted EPS are the same as the assumed exercise of stock options, warrants and restricted stock units are anti-dilutive.
Three Months Ended
June 30, 2026
Six Months Ended
June 30, 2025
2026202520262025
Net loss(8,098)(7,420)(73,633)(15,614)
Less: Change in fair value of March 2025 Warrants and March 2025 Private Placement Warrants(7,387)
Adjusted diluted net loss(15,485)(7,420)(73,633)(15,614)
Weighted average shares outstanding95,483,280 63,376,392 91,211,050 48,712,124 
Add: Dilutive effect of March 2025 Warrants and March 2025 Private Placement Warrants15,900,731 
Weighted average diluted shares outstanding111,384,01163,376,39291,211,05048,712,124
Net loss per share - basic$(0.08)$(0.12)$(0.81)$(0.32)
Net loss per share - diluted$(0.14)$(0.12)$(0.81)$(0.32)
Anti-dilutive Securities Excluded from Computation of Diluted Net Loss per Share
The following potential common shares were not considered in the computation of diluted net loss per share as their effect would have been anti-dilutive for the periods presented below:
Three Months Ended
June 30, 2026
Six Months Ended
June 30, 2025
2026202520262025
Warrants3,715,56122,904,87919,616,29222,904,879
Stock options7,813,7517,255,6357,813,7517,255,635
RSUs4,260,4242,091,2274,260,4242,091,227
Conversion shares525,015525,015
Total
16,314,75132,251,74132,215,48232,251,741